• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

后肾腺瘤:分子研究和文献复习。

Metanephric adenoma: molecular study and review of the literature.

机构信息

Pathology Department, University Hospital Virgen Macarena, Seville, Spain.

School of Medicine, University of Seville, Seville, Spain.

出版信息

Oncotarget. 2022 Feb 17;13:387-392. doi: 10.18632/oncotarget.28192. eCollection 2022.

DOI:10.18632/oncotarget.28192
PMID:35198098
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8852360/
Abstract

INTRODUCTION

Metanephric adenoma (MA) is an uncommon benign tumor accounting for 0.2-0.7% of adult renal epithelial neoplasms. The clinical course is often indolent, but diagnosis should not be delayed since clinical symptoms (hematuria, fever, palpable abdominal mass, and flank pain) may be non-specific and overlap with those of a malign renal neoplasm. We report on 4 cases of AM, for which morphological and mutational analysis were performed.

MATERIAL AND METHODS

Immunohistochemical staining was performed on sections cut from paraffin blocks to assess expression of WT1, vimentin, racemase, CK7, CD10 and RCC. Testing for the BRAF gene mutation V600 was carried out using real-time PCR (Cobas 4800).

RESULTS

In all four cases, tumors were visible as well-circumscribed, non-encapsulated masses located in the renal cortex and extending towards the medulla. At immunohistochemical examination, tumor cells stained negative for CK7, CD10 and RCC and positive for both WT1 (nuclear, intense) and vimentin (cytoplasmic, intense, and diffuse). Molecular analysis revealed the BRAF gene mutation V600E in three cases and wild-type BRAF in the fourth.

CONCLUSIONS

BRAF molecular mutation analysis may aid diagnosis in cases with atypical histological features, especially in small incisional biopsies when reassessment of surgical treatment may be considered.

摘要

介绍

后肾腺瘤(MA)是一种罕见的良性肿瘤,占成人肾上皮性肿瘤的 0.2-0.7%。其临床病程通常较为惰性,但由于临床症状(血尿、发热、可触及的腹部肿块和腰痛)可能不具特异性且与恶性肾肿瘤重叠,因此不应延误诊断。我们报告了 4 例 MA 的病例,对其进行了形态学和突变分析。

材料和方法

对石蜡块切片进行免疫组织化学染色,以评估 WT1、波形蛋白、racemase、CK7、CD10 和 RCC 的表达。使用实时 PCR(Cobas 4800)检测 BRAF 基因 V600 突变。

结果

在所有 4 例病例中,肿瘤均为边界清楚、无包膜的肿块,位于肾皮质并向髓质延伸。免疫组化检查显示,肿瘤细胞 CK7、CD10 和 RCC 均为阴性,WT1(核,强阳性)和波形蛋白(细胞质,强阳性,弥漫性)均为阳性。分子分析显示 3 例存在 BRAF 基因 V600E 突变,而第 4 例为野生型 BRAF。

结论

在具有非典型组织学特征的病例中,BRAF 分子突变分析可能有助于诊断,特别是在需要重新评估手术治疗的小切取活检中。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a960/8852360/8a26b7dfad32/oncotarget-13-28192-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a960/8852360/8a26b7dfad32/oncotarget-13-28192-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a960/8852360/8a26b7dfad32/oncotarget-13-28192-g001.jpg

相似文献

1
Metanephric adenoma: molecular study and review of the literature.后肾腺瘤:分子研究和文献复习。
Oncotarget. 2022 Feb 17;13:387-392. doi: 10.18632/oncotarget.28192. eCollection 2022.
2
Alpha-methylacyl-CoA racemase as a marker in the differential diagnosis of metanephric adenoma.α-甲基酰基辅酶A消旋酶作为后肾腺瘤鉴别诊断的标志物。
Mod Pathol. 2006 Feb;19(2):218-24. doi: 10.1038/modpathol.3800520.
3
Molecular and immunohistochemical characterization reveals novel BRAF mutations in metanephric adenoma.分子和免疫组化特征揭示了后肾腺瘤中的新型BRAF突变。
Am J Surg Pathol. 2015 Apr;39(4):549-57. doi: 10.1097/PAS.0000000000000377.
4
KANK1-NTRK3 fusions define a subset of BRAF mutation negative renal metanephric adenomas.KANK1-NTRK3融合基因定义了一部分BRAF突变阴性的肾后肾腺瘤。
BMC Med Genet. 2020 Oct 12;21(1):202. doi: 10.1186/s12881-020-01143-6.
5
[Molecular features of metanephric adenoma and their values in differential diagnosis].[后肾腺瘤的分子特征及其在鉴别诊断中的价值]
Zhonghua Bing Li Xue Za Zhi. 2017 Jan 8;46(1):38-42. doi: 10.3760/cma.j.issn.0529-5807.2017.01.009.
6
BRAF mutations in metanephric adenoma of the kidney.肾脏后肾腺瘤中的 BRAF 突变。
Eur Urol. 2012 Nov;62(5):917-22. doi: 10.1016/j.eururo.2012.05.051. Epub 2012 Jun 9.
7
Immunohistochemical phenotype and molecular pathological characteristics of metanephric adenoma.后肾腺瘤的免疫组织化学表型及分子病理学特征
Int J Clin Exp Pathol. 2015 Jun 1;8(6):6031-6. eCollection 2015.
8
Metanephric Adenoma-Epithelial Wilms Tumor Overlap Lesions: An Analysis of BRAF Status.后肾腺瘤-上皮性肾母细胞瘤重叠病变:BRAF 状态分析。
Am J Surg Pathol. 2019 Sep;43(9):1157-1169. doi: 10.1097/PAS.0000000000001240.
9
BRAF mutations in pediatric metanephric tumors.小儿后肾肿瘤中的BRAF突变
Hum Pathol. 2015 Aug;46(8):1153-61. doi: 10.1016/j.humpath.2015.03.019. Epub 2015 Apr 21.
10
[Clinicopathological features and differential diagnosis of metanephric adenoma: a report of sixteen cases].[肾母细胞瘤的临床病理特征及鉴别诊断:附16例报告]
Beijing Da Xue Xue Bao Yi Xue Ban. 2016 Aug 18;48(4):598-602.

引用本文的文献

1
Metanephric adenoma in a pediatric patient case report.小儿患者肾胚胎瘤病例报告
Front Pediatr. 2025 Apr 3;13:1539220. doi: 10.3389/fped.2025.1539220. eCollection 2025.
2
A giant metanephric adenoma in a young male.一名年轻男性体内的巨大后肾腺瘤。
J Surg Case Rep. 2023 Apr 11;2023(4):rjad187. doi: 10.1093/jscr/rjad187. eCollection 2023 Apr.
3
Atypical metanephric adenoma: Shares similar histopathological features and molecular changes of metanephric adenoma and epithelial-predominant Wilms' tumor.非典型后肾腺瘤:具有与后肾腺瘤和上皮为主型肾母细胞瘤相似的组织病理学特征及分子改变。

本文引用的文献

1
Metanephric adenoma with BRAF V600K mutation and a doubtful radiological imaging: pitfalls in the diagnostic process.伴 BRAF V600K 突变的后肾腺瘤及可疑影像学表现:诊断过程中的陷阱。
Med Mol Morphol. 2021 Jun;54(2):187-191. doi: 10.1007/s00795-020-00269-z. Epub 2020 Nov 11.
2
KANK1-NTRK3 fusions define a subset of BRAF mutation negative renal metanephric adenomas.KANK1-NTRK3融合基因定义了一部分BRAF突变阴性的肾后肾腺瘤。
BMC Med Genet. 2020 Oct 12;21(1):202. doi: 10.1186/s12881-020-01143-6.
3
Molecular characterisation of metanephric adenomas beyond BRAF: genetic evidence for potential malignant evolution.
Front Oncol. 2022 Oct 14;12:1020456. doi: 10.3389/fonc.2022.1020456. eCollection 2022.
肾后肾腺瘤超出BRAF基因的分子特征:潜在恶性进展的遗传学证据
Histopathology. 2020 Jun;76(7):1084-1090. doi: 10.1111/his.14094. Epub 2020 May 11.
4
Metanephric Adenoma-Epithelial Wilms Tumor Overlap Lesions: An Analysis of BRAF Status.后肾腺瘤-上皮性肾母细胞瘤重叠病变:BRAF 状态分析。
Am J Surg Pathol. 2019 Sep;43(9):1157-1169. doi: 10.1097/PAS.0000000000001240.
5
Novel clinicopathological and molecular characterization of metanephric adenoma: a study of 28 cases.后肾腺瘤的新型临床病理及分子特征:28例病例研究
Diagn Pathol. 2018 Aug 16;13(1):54. doi: 10.1186/s13000-018-0732-x.
6
[Adenoma metanephric: Report of 2 cases and bibliographic review.].[后肾腺瘤:2例报告及文献复习。]
Arch Esp Urol. 2017 Nov;70(9):792-796.
7
Distinct clinicopathological features in metanephric adenoma harboring BRAF mutation.携带BRAF突变的后肾腺瘤的独特临床病理特征。
Oncotarget. 2016 Aug 8;8(33):54096-54105. doi: 10.18632/oncotarget.11117. eCollection 2017 Aug 15.
8
A Rare Finding of a BRAF Mutation in Renal Cell Carcinoma with Response to BRAF-Directed Targeted Therapy.肾细胞癌中BRAF突变的罕见发现及对BRAF靶向治疗的反应
Cureus. 2016 Jan 6;8(1):e449. doi: 10.7759/cureus.449.
9
Immunohistochemical phenotype and molecular pathological characteristics of metanephric adenoma.后肾腺瘤的免疫组织化学表型及分子病理学特征
Int J Clin Exp Pathol. 2015 Jun 1;8(6):6031-6. eCollection 2015.
10
Metanephric adenoma: the utility of immunohistochemical and cytogenetic analyses in differential diagnosis, including solid variant papillary renal cell carcinoma and epithelial-predominant nephroblastoma.后肾腺瘤:免疫组织化学和细胞遗传学分析在鉴别诊断中的应用,包括实性变异型乳头状肾细胞癌和上皮优势型肾母细胞瘤。
Mod Pathol. 2015 Sep;28(9):1236-48. doi: 10.1038/modpathol.2015.81. Epub 2015 Aug 7.